ARCHIVES

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

Reviewers Report Progress In New Drug Prescreen System Development, Commend DTP

December 15, 1989

Screening Guidelines: When Scientists Can’t Agree, What’s The Press To Do?

May 15, 1998

Natural Substance Blocks Androgen Activity In Vitro

April 27, 2001

“Wild West” of Molecular Testing?: Caris Engaged in Aggressive Marketing, Improper Medicare Billing, Lawsuit Alleges

August 8, 2014

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006

Rejecting Data, Believers In PSA Screening Strengthen Guidelines, Launch Outreach

September 11, 2009